Showing results (141-150 of 177) with videos related to

Sort By:
Pageof 18
Immunity|May 12, 2021
The inhibitory receptor TIM-3 limits activation of the cGAS-STING pathway in intra-tumoral dendritic cells by suppressing extracellular DNA uptakeÁlvaro de Mingo Pulido, Kay Hänggi, Daiana P Celias, et al.
Clinical Breast Cancer|August 30, 2016
Ramucirumab With Eribulin Versus Eribulin in Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy: A Multicenter, Randomized, Phase II StudyDenise A Yardley, James Reeves, E Claire Dees, et al.
Contemporary Clinical Trials|September 24, 2025
Design of a cluster randomized multi-level intervention to decrease barriers to minority cancer patient referral and enrollment to cancer clinical trials: The ACT WONDER2S studyDana E Rollison, Melany A Garcia, Rossybelle P Amorrortu, et al.
Journal of Family Medicine and Primary Care|July 15, 2026
Assessing cognitive impairment in Saudi Arabian diabetes patients: A cross-sectional study in Aseer regionEman Ali Alqahtani, Hassan Misfer N Taresh, Abdulaziz S Alserhani, et al.
European Heart Journal. Cardiovascular Imaging|September 24, 2022
EACVI SIMULATOR-online study: evaluation of transoesophageal echocardiography knowledge and skills of young cardiologistsThéo Pezel, Augustin Coisne, Błażej Michalski, et al.
Cureus|January 15, 2026
Fragility Femoral and Hip Fractures in Saudi Arabia: A Systematic Review of Epidemiology, Risk Factors, Clinical Outcomes, and Health-System GapsMohaned S Argan, Hatem Soliman Ali Alwalidi, Lamar Tariq Alassiry, et al.
Breast Cancer Research and Treatment|March 13, 2019
Clinical outcomes of breast leptomeningeal disease treated with intrathecal trastuzumab, intrathecal chemotherapy, or whole brain radiation therapyNicholas B Figura, Victoria T Rizk, Homan Mohammadi, et al.
JACC. Cardiovascular Imaging|July 18, 2024
Dapagliflozin Effects on Cardiac Deformation in Heart Failure and Secondary Clinical OutcomeMaria Concetta Pastore, Andrea Stefanini, Giulia Elena Mandoli, et al.
JAMA Oncology|December 5, 2024
Alteration of the Tumor Microenvironment With Intratumoral Dendritic Cells Before Chemotherapy in ERBB2 Breast Cancer: A Nonrandomized Clinical TrialHyo S Han, Amy L Aldrich, Saurabh K Garg, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 7, 2021
Th1 cytokine interferon gamma improves response in HER2 breast cancer by modulating the ubiquitin proteasomal pathwayYongsheng Jia, Krithika N Kodumudi, Ganesan Ramamoorthi, et al.
Pageof 18